European Pharmacopoeia Ph Eur Monograph Tablets 0478 Better Upd Here
The European Pharmacopoeia (Ph. Eur.) General Monograph 0478 sets the essential quality and manufacturing standards for Tablets (Compressi). This general monograph applies to all tablets unless a specific product monograph states otherwise, providing the legal and scientific basis for their quality control in Europe.
Below are the key requirements and test criteria summarized from the monograph: 1. Definition and Manufacture
Formulation: Tablets are solid preparations containing one or more active substances, usually obtained by compressing uniform volumes of particles.
Physical Characteristics: Typically straight, circular cylinders with flat or convex surfaces and potentially beveled edges. They may be coated or bear functional break-marks (scores).
Microbiological Quality: Suitable measures must be taken during manufacture and storage to ensure compliance with General Chapter 5.1.4. 2. Functional Requirements for Scored Tablets (Subdivision)
If a tablet has a break-mark to allow for fractional dosing, the effectiveness of that break-mark must be validated:
Testing Procedure: 30 tablets are randomly selected and broken by hand. One part from each tablet is weighed. Acceptance Criteria:
Pass: No more than 1 individual mass is outside 85–115% of the average mass.
Fail: If more than 1 mass is outside the 85–115% range, or if any single mass is outside 75–125% of the average. 3. Routine Quality Control Tests
Tablets must generally comply with the following standardized tests: european pharmacopoeia ph eur monograph tablets 0478 better
3. Critical Quality Attributes (Testing Requirements)
The monograph outlines specific tests to ensure batch-to-batch consistency and patient safety.
Conclusion: Be Better with Ph. Eur. Monograph 0478
Searching for "european pharmacopoeia ph eur monograph tablets 0478 better" suggests you are not just looking for a definition—you are looking for a strategy. The "better" aspect of Monograph 0478 lies in its holistic, no-compromise view of tablet quality.
It forces you to control your granulation, predict your dissolution, and prove your uniformity. While the USP might allow a Cpk of 1.0, Ph. Eur. 0478 silently demands a Cpk of 1.33. That is the difference between a passable doctor and a reliable one.
Action Item for Quality Leaders:
- Download the latest Ph. Eur. 0478 from the EDQM website.
- Run a side-by-side comparison of your top three products against the 0478 parameters.
- Retrofit your stability chambers to meet the humidity clauses for friability testing.
Do not just comply. Be better. Follow Ph. Eur. Monograph 0478.
Disclaimer: This article is for informational purposes only. Always refer to the official European Pharmacopoeia published by the EDQM for legal requirements. Regulatory timelines and monograph numbers are subject to change.
The European Pharmacopoeia (Ph. Eur.) Monograph 0478 provides the general quality standards for tablets intended for oral administration. It covers a variety of types, including uncoated, coated, gastro-resistant, and modified-release tablets. Key Quality Requirements
According to the Monograph 0478 overview, tablets must generally meet these technical standards:
Uniformity of Mass (2.9.5): Requires testing a random sample of 20 tablets. Compliance is achieved if no more than 2 individual masses deviate by more than the specified percentage from the average mass, and none deviate by more than double that percentage. The European Pharmacopoeia (Ph
Uniformity of Content (2.9.6): Mandatory for tablets with active substance content less than 2 mg or less than 2% of the total mass.
Disintegration (2.9.1): Most uncoated tablets must disintegrate within 15 minutes using water at . Coated tablets typically have a limit of 60 minutes.
Dissolution (2.9.3): A product-specific test must be established to ensure the active ingredient is released appropriately. Recent policy updates require a dissolution or disintegration test for all immediate-release solid dosage forms. Important Technical Sections
Subdivision of Scored Tablets: For tablets with break-marks, the Ph. Eur. requirements for scored tablets dictate that the break-marks must be functional and ensure the uniformity of mass of the subdivided parts.
Production Standards: Manufacturers must ensure that tablets are sufficiently hard to withstand handling but still meet disintegration/dissolution targets. Specific tests for Friability (2.9.7) and Resistance to Crushing (2.9.8) are standard in the production phase. Recent Updates
The monograph has seen significant revisions in recent supplements: Revised Ph. Eur. Chapter Tablets - ECA Academy
The European Pharmacopoeia (Ph. Eur.) monograph 0478 provides the mandatory quality standards for intended for human use
. It defines tablets as solid preparations containing a single dose of one or more active substances, obtained by compressing uniform volumes of particles. gmp-compliance.org Core Quality Requirements
According to the monograph and related general chapters, tablets must meet specific criteria for safety and efficacy: Download the latest Ph
Uniformity of content in de Ph. Eur. 1999 - Universiteit Utrecht
The European Pharmacopoeia (Ph. Eur.) Monograph 0478 is the definitive general monograph governing the quality, production, and testing standards for Tablets within the European Union. Understanding this monograph is essential for pharmaceutical manufacturers to ensure batch-to-batch consistency and regulatory compliance. Core Requirements of Monograph 0478
The monograph establishes a strict framework for several categories of oral tablets, including uncoated, coated, gastro-resistant, and modified-release types.
Production Standards: Manufacturers must ensure that tablets are robust enough to withstand handling while maintaining precise delivery of the active substance.
Subdivision (Scored Tablets): If a tablet is designed to be broken, the "break-marks" must be functional. Ph. Eur. 0478 requires that subdivided parts meet specific uniformity of mass standards to prevent unpredictable dosing.
Uniformity of Content & Mass: Tablets with less than 2 mg of active substance or those making up less than 2% of total mass must comply with stringent "Uniformity of Content" tests to ensure each dose is accurate. Key Testing Protocols
To achieve "better" compliance and product quality, manufacturers must adhere to these standardized tests: gmp-compliance.org Revised Ph. Eur. Chapter Tablets - gmp-compliance.org
1. Scope & Definition
Monograph 0478 defines tablets as "solid preparations each containing a single dose of one or more active substances." They are obtained by compressing uniform volumes of particles or by other methods of manufacture (e.g., moulding).
Cammilla's Korean